Vinod Tiwari Selected Research

tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)

1/2021	Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry.
3/2016	Activation of Peripheral μ-opioid Receptors by Dermorphin [D-Arg2, Lys4] (1-4) Amide Leads to Modality-preferred Inhibition of Neuropathic Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinod Tiwari Research Topics

Disease

25	Pain (Aches) 05/2022 - 10/2010
22	Neuralgia (Stump Neuralgia) 01/2022 - 09/2009
11	Chronic Pain 05/2022 - 02/2014
11	Hypersensitivity (Allergy) 04/2022 - 02/2014
10	Cognitive Dysfunction 10/2021 - 04/2009
6	Inflammation (Inflammations) 10/2021 - 12/2009
5	Hyperalgesia 01/2020 - 09/2009
4	Neoplasms (Cancer) 01/2022 - 10/2015
4	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 08/2009
3	Cockayne Syndrome (Syndrome, Cockayne) 01/2021 - 12/2020
3	Body Weight (Weight, Body) 12/2019 - 10/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2019 - 06/2017
3	Hyperglycemia 01/2019 - 10/2010
3	Neuroinflammatory Diseases 10/2018 - 08/2012
3	Alcoholic Neuropathy (Alcoholic Polyneuropathy) 11/2012 - 09/2009
2	Schizophrenia (Dementia Praecox) 10/2022 - 12/2017
2	Diabetic Neuropathies (Diabetic Neuropathy) 12/2020 - 10/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018 - 08/2009
2	Peripheral Nerve Injuries 01/2014 - 08/2013
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 06/2010 - 12/2009
1	Neurobehavioral Manifestations 10/2022
1	Necrosis 05/2022
1	Cytokine Release Syndrome 04/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2011
7	Ethanol (Ethyl Alcohol)IBA 10/2021 - 09/2009
6	KinesinsIBA 05/2022 - 06/2019
6	Opioid Analgesics (Opioids)IBA 01/2021 - 02/2014
6	CytokinesIBA 11/2019 - 10/2010
6	TocotrienolsIBA 11/2012 - 04/2009
5	Analgesics (Analgesic Drugs)IBA 05/2022 - 02/2014
5	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2021 - 12/2009
5	LipidsIBA 09/2021 - 01/2018
5	Insulin (Novolin)FDA Link 01/2020 - 10/2010
5	Protein Isoforms (Isoforms)IBA 04/2014 - 08/2009
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 11/2021 - 03/2014
4	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 02/2014
4	AntioxidantsIBA 12/2017 - 12/2009
4	Vitamin E FDA LinkGeneric 11/2012 - 08/2009
3	tozasertibIBA 05/2022 - 01/2021
3	Aurora KinasesIBA 05/2022 - 01/2021
3	Protein Kinases (Protein Kinase)IBA 12/2020 - 01/2018
3	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 02/2014
3	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 12/2018
3	EnzymesIBA 06/2019 - 12/2009
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 08/2014
3	AcetylcholinesteraseIBA 12/2012 - 06/2011
3	Glutathione (Reduced Glutathione)IBA 06/2011 - 09/2009
3	alpha-Tocopherol FDA Link 11/2009 - 08/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 05/2022 - 11/2019
2	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2014
2	CurcuminIBA 01/2022 - 12/2012
2	LigandsIBA 01/2022 - 01/2021
2	CamphorIBA 01/2022 - 08/2021
2	Phosphotransferases (Kinase)IBA 09/2021 - 01/2019
2	tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA 01/2021 - 03/2016
2	Chemokine ReceptorsIBA 01/2021 - 10/2018
2	ChemokinesIBA 01/2021 - 09/2014
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 12/2018
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 12/2015
2	Thymidine Monophosphate (TMP)IBA 12/2019 - 11/2019
2	Blood Glucose (Blood Sugar)IBA 12/2019 - 11/2019
2	dermorphinIBA 01/2018 - 03/2016
2	AmidesIBA 01/2018 - 03/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 12/2009
2	Bisbenzimidazole (Hoechst 33258)IBA 01/2017 - 01/2012
2	bovine adrenal medulla 8-22IBA 01/2017 - 03/2014
2	Peptides (Polypeptides)IBA 02/2015 - 03/2014
2	PotassiumIBA 01/2014 - 08/2013
2	Caspase 3 (Caspase-3)IBA 12/2012 - 10/2010
2	sesamolIBA 06/2011 - 10/2010
2	Streptozocin (Streptozotocin)FDA Link 06/2011 - 08/2009
2	Superoxide DismutaseIBA 12/2009 - 09/2009
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 05/2022
1	InterleukinsIBA 05/2022
1	scutigeralIBA 01/2022
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2022
1	piperineIBA 01/2022
1	Monoacylglycerol LipasesIBA 01/2022
1	isovelleralIBA 01/2022
1	capsazepineIBA 01/2022
1	pellitorineIBA 01/2022
1	evodiamineIBA 01/2022
1	EugenolIBA 01/2022
1	zingeroneIBA 01/2022
1	shogaolIBA 01/2022
1	GinsenosidesIBA 01/2022
1	SemicarbazonesIBA 01/2022
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2022
1	CannabidiolIBA 01/2022
1	allicinIBA 01/2022
1	Yohimbine (Yocon)IBA 01/2022
1	ricinoleic acid (ricinelaidic acid)IBA 01/2022

Therapy/Procedure

16	Therapeutics 01/2022 - 02/2015
7	Drug Therapy (Chemotherapy) 01/2022 - 10/2011
5	Ligation 03/2016 - 01/2014
2	Analgesia 01/2020 - 02/2014
2	Spinal Injections 03/2014 - 03/2014